Colchicine for myocardial infarction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jul 2022: Trial registered, NCT05472337
  2. 1 Aug 2022: Trial started, NCT05472337

The trials

NCT05472337: Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

State
Under way
Phase
Phase 2
People
50 planned
Started
1 Aug 2022
Primary completion
30 Mar 2026
Arms
Colchicine
Results
None posted
  1. 25 Jul 2022: Trial registered
  2. 1 Aug 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Colcrys, Colchicine 0.6 mg, Colchicine 1 MG Oral Tablet, Colchicine Tablets, Colchicine only, Gloperba, Lodoco, Mitigare component colchicine, Myinfla.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.